Publications for medical devices, from dataset to PubMed

Your data sits in reports, study folders and patient records. We turn it into a manuscript, recruit the co-authors and guide it through peer review until it is listed in PubMed.

The data usually exist already. So far, nobody has written them up.

01
PDF
Clinical_Investigation_Report.pdfRegulatory folder · filed 2023
  • Notified Bodyaccepted
  • Physicians informedno
  • Publicationnone
Unread since 2023

The study was only for the Notified Body. The clinical investigation report served its purpose and has been sitting in a folder ever since. No physician knows the results, including the negative ones that would spare other users mistakes.

02
Consultant rotaWk 46
MonTueWedThuFriSatSun
Write paper not scheduledfor 7 months

The consultant wants to, but never gets round to it. The cases are documented, the idea for the paper is there. Between theatre, ward and on-call duty, nothing has come of it for months.

03
Vienna Istanbul Bogotá

Sales needs data from the country. For Austria, Turkey or Colombia, case reports and case series from local hospitals count. Only then will the consultant there believe your figures.

From case report to consensus statement.

6 formats, depending on which data you have and what the publication should achieve.

Clinical Investigation Report
Final report of the clinical investigation
Methods
Results
Original Article · peer-reviewed
Results of the clinical investigation in routine care
Abstract
Discussion

Publication from a clinical investigation report. Your study is finished for the Notified Body. We turn it into a paper that also convinces reviewers and readers.

Patient 01 · CourseExample values
Day 5: stableafter use of the product

Case report. A single, well-documented patient case. The fastest route to a first publication featuring your product.

Case series · 12 patients3 hospitals
Hospital AHospital BHospital C

Case series. Several cases from one or more hospitals. Ideal for showing experience from one country or a new indication.

Routine data · AnalysisExample values
SitePeriodn
University hospital A2019–202348
Hospital B2020–202331
Hospital C2021–202322
Hospital D2022–202313
Total4 sites114

Retrospective study. The analysis of existing routine data, often from several sites. Robust enough for the Notified Body and for conversations with hospitals.

Study 2019Randomised
Study 2021Registry
Study 2022Case series
Review articleEvidence put in context

Review article. The body of evidence on your therapy, neatly summarised and put in context. Useful when you do not yet have your own data.

Consensus statement. Experts from hospitals agree on a recommendation, and we moderate and write. This is how widespread use becomes a standard.

Recommendation unanimous

5 steps that we take over completely.

You provide access and approvals. We handle everything in between.

Manuscript · DraftExample
Use in everyday clinical practice: retrospective analysis from 4 sites
Physician A, Consultant B, Head of Department C, P. Recknagel
Ethics approvalConsentsConflicts of interest
Research question: What do the data support, and which journal is the right fit?
Abstract
Discussion
Reviewer 1Please describe the follow-up in more detail.
Response incorporatedMethods section expanded.
PPubMed
Use in everyday clinical practice: retrospective analysis from 4 sitesScientific journal, peer-reviewed · ExampleListed and discoverable
  1. 01
    Data and research question

    We review what is available and determine which message the paper can support and which journal fits.

  2. 02
    Manuscript

    Literature search, storyline and the complete text from abstract to discussion.

  3. 03
    Co-authors and approvals

    We recruit the physicians as co-authors and align with them and your team. Ethics approval, consents and conflicts of interest are settled before submission.

  4. 04
    Submission and peer review

    We submit, answer the reviewers' questions and incorporate the revisions.

  5. 05
    Listed in PubMed

    The paper is published, and your field sales team has it with them in the next hospital conversation.

The first draft is on your desk after 72 hours.

Once all data are available, you receive a case report or case series as a complete draft after 72 hours, and a retrospective study after about 1 week. For a white paper or the publication of a large study from a clinical investigation report, allow about 2 weeks.

What takes longer is whatever comes from outside. An ethics committee often meets only once a month, physicians and your team need time for their revisions, and peer review itself takes a few weeks to months depending on the journal. We plan for that from the start.

Data availableStart
72 hoursFirst draft
2 weeksLarge study, white paper
Ethics committeeOften meets once a month
Peer reviewWeeks to months

This is how it looks for other manufacturers.

"After the research question had been formulated and the available data discussed, the lines of work to be addressed were clearly set out and, in close exchange, brought to publication readiness. This continued just as constructively through the review process."
Dr. med. Frank W. Kornitzky · Lead consultant, intensive care medicine

When do you have to start on evidence at the latest?

Answer 18 short questions about your product. You then receive your Evidence Plan as a PDF: which building blocks must be ready by your next deadline, when you have to start at the latest, and what budget to expect.

Create your Evidence Plan Takes 4 minutes, is confidential and free of charge.
Example of the Evidence Plan result: deadline, latest start, budget range and timeline of the building blocks

This is what your result looks like (example)

Questions about publications.

What manufacturers most often want to know before a publication.

Dr. Peter Recknagel
Your question is not listed?Write to me directly.
View all questions

The physicians and, if you wish, your team. We do not have to be named on the paper. For many manufacturers this is precisely an advantage: you do not have to declare a conflict of interest. On request, we are named as a co-author or as the medical writer in the acknowledgements. We clarify this openly in advance, as journals require.

Publication is worthwhile even then. Showing where a product does not help protects patients and earns the trust of physicians. How we position the result, we discuss with you before submission.

Nobody can credibly promise that. We choose the journal to match the message and support every revision. If a journal rejects the paper, we submit to the next suitable one.

That depends on the study type and the hospital. If one is needed, we write the application and align it with the hospital.

What data do you have sitting in a drawer?

In the evidence call we spend 30 minutes looking at what you have, and tell you which paper it could become.